Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Lenercept evaluated in phase II for sepsis/septic shock; development for RA halted

Oct. 15, 1997

New agent for restenosis reported by Taiho

Oct. 15, 1997

KRM-1648: a rifamycin derivative active against H. pylori and Mycobacterium spp.

Oct. 15, 1997

Echinocandin antifungal agent tested in patients

Oct. 15, 1997

Feasibility of OROS melatonin delivery evaluated in humans

Oct. 15, 1997

Sensus reports early clinical results with B2036-PEG

Oct. 15, 1997

Preliminary human evaluation of DMP-543, a potential antidementia agent

Oct. 15, 1997

Safety and pharmacokinetics of new hyperlipidemia Rx in humans

Oct. 15, 1997

Phase I/II results reported for lobucavir in HBV

Oct. 15, 1997

S-4661 efficacy demonstrated in RTI, UTI

Oct. 14, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...